Joshua S. Baugher - 08 Apr 2026 Form 4 Insider Report for ARGAN INC (AGX)

Reporting relationship: Chief Financial Officer
Issuer ticker: AGX
Reported as of: 08 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Apr 2026, 16:30:15 UTC
Prior SEC filing: 06 May 2025
Next SEC filing: 20 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Joshua S. Baugher

Key filing fact

Joshua S. Baugher filed Form 4 for ARGAN INC (AGX) on 10 Apr 2026.

Key facts

This page summarizes Joshua S. Baugher's Form 4 filing for ARGAN INC (AGX).
4 reported transactions and 4 derivative rows are listed below.
Accepted by SEC: 10 Apr 2026, 16:30.

Change

Previous filing in this sequence was filed on 06 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002066213 Primary reporting owner

Baugher Joshua Scott

Relationship: Chief Financial Officer
Address: 4075 WILSON BOULEVARD, SUITE 440, ARLINGTON
Signature: /s/ Joshua S. Baugher
Signature date: 10 Apr 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AGX transaction Derivative

Option to Purchase Common Stock

Award

Transaction value
Shares: +208
Change %: +8.3%
Price: $0.000000^*
Shares after: 2,708
Date: 08 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 208
Exercise price: $588.28
Footnotes: F1

AGX transaction Derivative

Time-Based Restricted Stock Units

Award

Transaction value
Shares: +126
Change %: +2.7%
Price: $0.000000^*
Shares after: 4,710
Date: 08 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 126
Exercise price: $0.000000
Footnotes: F2

AGX transaction Derivative

Performance-Based Restricted Stock Units

Award

Transaction value
Shares: +142
Change %: +9.5%
Price: $0.000000^*
Shares after: 1,642
Date: 08 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 142
Exercise price: $0.000000
Footnotes: F3

AGX transaction Derivative

Earnings Per Share Performance-Based Restricted Stock Units

Award

Transaction value
Shares: +1,670
Change %: +45%
Price: $0.000000^*
Shares after: 5,420
Date: 08 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,670
Exercise price: $0.000000
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

On April 8, 2026, the Reporting Person was granted a 10-year option to purchase 208 shares of the Issuer's common stock at an exercise price of $588.28 per share. The options will vest ratably over three years on each anniversary of the grant date starting on 4/8/2027.

Footnote F2

On April 8, 2026, the Reporting Person was granted TRSUs covering 126 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/8/2027.

Footnote F3

On April 8, 2026, the Reporting Person was granted Performance-Based Restricted Stock Units ("PRSUs") in the target number of 142 shares, the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2026 Proxy Statement. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the target number of 142 shares, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

Footnote F4

On April 8, 2025, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 1,670 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2027, 2028 and 2029 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2024, 2025 and 2026. The pay-out ratio of the target number of 1,670 shares, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period.